Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 7/24/18 (What's New)

Supporting Assets

Figure 1 | Figure 2 | Figure 3 | Figure 4 | Figure 5 | Figure 6 | Figure 7 | Figure 8 | Figure 9 | Table 1 | Table 2 | Table 3 | Table 4 | Table 5 | Table 6 | Table 7 | Table 8 | Table 9 | Table 10 | Table 11 | Table 12 | Table 13 | Table 14 | Table 15 | Table 16 | Table 17 | Table 18 | Table 19 | Table 20 | Table 21 | Table 22 | Table 23 | Table 24 | Table 25 | Table 26 | Table 27 | Table 28 | Table 29 | Table 30 | Table 31 | Table 32 | Table 33 | Table 34 | Table 35 | Table 36 | Table 37 | Table 38 | Table 39 | Table 40 | Table 41 | Table 42 | Video 1 | Video 2

Figure 1. HCV viral life cycle and DAA targets.

...

Action required

Keywords: Hepatitis C-Treatment

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.